Gagelmann N, Badbaran A, Salit RB, et al. Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation. Blood. 2023;141(23):2901-2911

Blood. 2024 May 2;143(18):1879. doi: 10.1182/blood.2024024466.
No abstract available

Publication types

  • Letter
  • Published Erratum

MeSH terms

  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Male
  • Primary Myelofibrosis* / blood
  • Primary Myelofibrosis* / therapy
  • Prognosis
  • Treatment Outcome
  • Tumor Suppressor Protein p53* / genetics

Substances

  • Tumor Suppressor Protein p53
  • TP53 protein, human